BamSEC and AlphaSense Join Forces
Learn More

Fuisz Technologies Ltd

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from SC 13D/A 1 page The Directors Biovail Corporation International 2488 Dunwin Drive Mississauga Ontario Canada 23rd July 1999 Fuisz Technologies Ltd. Dear Sirs This Letter Confirms the Irrevocable Agreement of Westbury Ltd to Accept the Unconditional Offer of Biovail Corporation International (Biovail) of US$7 Per Share Cash in Respect of Its Holding of 900,000 Shares of Common Stock in Fuisz Technologies Ltd. (Fuisz). Payment to Be Made to Westbury Ltd. Within Seven Days of the Delivery to Biovail of the Stock Certificate in Respect of the Stock Being Sold. Biovail May Rely on This Commitment to Sell Which Is an Enforceable Commitment. Kindly Note That Westbury Ltd. Is a Wholly-Owned Subsidiary of the Cross Group (Cross). Cross Received 1,000,000 Shares of Common Stock in Fuisz on 1st September 1997 as Part Consideration for the Sale of Its Subsidiary, Clonmel Healthcare Ltd. to Fuisz. Under the Sale and Purchase Agreement of 1st September 1997 Between Cross and Fuisz, Cross Is Restricted to Selling Not More Than 500,000 Shares in Fuisz Up to 1st September 1999. After That Date (Or Before That Date With the Consent of Fuisz) Cross Is Free to Sell the Entire Shareholding of 1,000,000 Shares. in April 1999 Cross Transferred 900,000 of Its Shares in Fuisz to Westbury Ltd. and a Further 100,000 Shares in Fuisz to Salisbury Ltd. (Also a Wholly Owned Subsidiary of Cross). Yours Faithfully /S/ D.P.N. Tierney D.P.N. Tierney Director
12/34/56
EX-2
from SC 13D ~10 pages Escrow Agreement
12/34/56